Journal of AI-Powered Medical Innovations (International online ISSN 3078-1930)
The title "Journal of AI-Powered Medical Innovations" conveys a focus on the transformative role of artificial intelligence (AI) in driving advancements in the medical field. The journal likely explores how AI technologies are being harnessed to innovate across various aspects of healthcare, from diagnostics and treatment to drug discovery and healthcare delivery. It suggests a publication that is dedicated to presenting research, reviews, and case studies on the integration of AI with medical science, highlighting breakthroughs, challenges, and the future potential of AI in revolutionizing medicine.
An Explainable ERP-Integrated Predictive Analytics Framework for Manufacturing Defect Risk Reduction
In the manufacturing sector, companies are increasingly turning to enterprise resource planning (ERP) to organise supply chain management, production, maintenance, quality control and inventory management, but ERP systems are usually not proactive in managing defect risk. The study suggests an explainable ERP integrated predictive analytics framework to support the reduction of manufacturing defect risks. The framework, based on 3,240 manufacturing defect records and 16 operational variables, maps variables to ERP domains of risk, engineers 7 composite risk indicators, applies three class-imbalance resampling strategies and assesses nine machine-learning models, including a stacking ensemble of gradient-boosted learners. Random Forest had the best F1 (0.969), recall (0.989), and false-negative rate (0.011) of all the classifiers. SHAP-based explainability pinpointed MaintenanceHours, QualityScore, and ProductionVolume as major drivers for defect risk, and turned them into conditional ERP decision rules for procurement, maintenance, quality, and inventory.
Copyright (c) 2025 Journal of AI-Powered Medical Innovations and Authors https://creativecommons.org/licenses/by/4.0/
Multi-Agent AI Systems for Intelligent Healthcare Workflow Optimization: A Framework for Safety, Scalability, and Regulatory Compliance
Healthcare systems worldwide face increasing operational complexity due to growing patient volumes, workforce shortages, fragmented health information systems, and stringent regulatory requirements. Conventional Artificial Intelligence (AI) solutions often address isolated clinical tasks but lack the collaborative intelligence required to coordinate multidisciplinary healthcare workflows across dynamic hospital environments. Multi-Agent Artificial Intelligence (MAAI) systems have emerged as a transformative paradigm by enabling multiple autonomous yet cooperative intelligent agents to perceive, reason, communicate, and make distributed decisions in real time. These systems facilitate seamless coordination among clinical decision support, patient monitoring, resource management, diagnostic assistance, scheduling, and regulatory compliance while maintaining human oversight and patient safety. This paper proposes a comprehensive framework for Multi-Agent AI Systems for Intelligent Healthcare Workflow Optimization that integrates autonomous clinical agents, workflow orchestration agents, knowledge management agents, safety assurance agents, and regulatory compliance agents into a unified healthcare ecosystem. The proposed framework leverages advanced machine learning, large language models (LLMs), explainable artificial intelligence (XAI), federated learning, cloud-edge computing, and interoperability standards such as HL7 FHIR to optimize end-to-end healthcare operations. Furthermore, the framework incorporates privacy-preserving mechanisms, continuous risk assessment, human-in-the-loop decision-making, and adaptive governance strategies to ensure compliance with healthcare regulations including HIPAA, GDPR, FDA guidance for AI-enabled medical devices, and ISO safety standards. The study presents an architectural perspective demonstrating how coordinated intelligent agents can improve patient throughput, clinical decision accuracy, operational efficiency, scalability, and healthcare resilience while reducing medical errors, resource bottlenecks, and administrative burdens. The framework also addresses key implementation challenges related to cybersecurity, interoperability, trustworthiness, ethical AI, model governance, and real-time collaboration across heterogeneous healthcare infrastructures. By integrating safety, scalability, and regulatory compliance into distributed intelligent decision-making, the proposed framework provides a robust foundation for developing next-generation autonomous healthcare systems capable of supporting sustainable digital transformation in modern hospitals and smart healthcare environments.
Explainable Artificial Intelligence (XAI)
Advanced Integration Architectures: SAP QM with MuleSoft, TIBCO, and LIMS
The pharmaceutical, biotechnology, and medical device industries depend on tightly integrated enterprise technology ecosystems to maintain product quality, regulatory compliance, and operational efficiency. SAP S/4HANA Quality Management (QM) serves as the central quality orchestration platform for many life sciences organizations, yet its full potential is realized only when it is deeply connected to adjacent enterprise systems, including integration middleware platforms, laboratory information management systems, and manufacturing execution systems. This study examines advanced integration architectures that connect SAP QM with MuleSoft Anypoint Platform, TIBCO BusinessWorks, and leading LIMS solutions, including LabWare, Lab Vantage, and STARLIMS. Drawing on SAP integration documentation, vendor technical references, applicable regulatory frameworks including 21 CFR Part 11 and EU GMP Annex 11, and published academic and practitioner literature, this paper analyzes the architectural patterns, data flow models, and governance implications of enterprise integration in GMP-regulated quality management environments. The findings demonstrate that event-driven and API-led connectivity architectures substantially improve data latency, inspection traceability, and cross-system audit trail integrity compared to point-to-point integration approaches. A Reference Integration Architecture (RIA) is proposed to guide organizations in designing scalable, compliant, and maintainable integration ecosystems centered on SAP QM.
Copyright (c) 2024 Journal of AI-Powered Medical Innovations and Authors https://creativecommons.org/licenses/by/4.0/
Enhancing Enterprise Performance Through Oracle Exadata: Advanced Optimization Techniques for High-Volume Workloads
Oracle Exadata Database Machine represents the most advanced hardware-software engineered system available for enterprise database workloads, combining specialized storage cells, intelligent offloading via Smart Scan, high-bandwidth InfiniBand interconnects, and an integrated Hybrid Columnar Compression (HCC) engine. Despite the platform's inherent capabilities, organizations operating high-volume transactional and analytical workloads frequently fail to extract maximum performance due to suboptimal configuration, inadequate workload isolation, and underutilization of Exadata-specific optimization features. This paper presents a comprehensive examination of advanced optimization techniques applicable to Oracle Exadata environments processing high-volume workloads, with particular focus on Smart Scan offloading, Storage Index utilization, Hybrid Columnar Compression strategies, Resource Manager configuration, I/O Resource Management (IORM), and SQL tuning frameworks tailored to the Exadata architecture. Drawing on real-world deployment scenarios in the healthcare insurance sector, performance benchmark data, and empirical tuning outcomes, this paper proposes an integrated optimization framework designated the Exadata Performance Optimization Framework (EPOF) that provides enterprise DBAs with a structured methodology for achieving measurable throughput improvements, latency reduction, and resource consolidation on Oracle Exadata platforms. Results demonstrate that systematic application of EPOF techniques yields query throughput improvements of up to 72 percent, I/O latency reductions of 65 percent, and storage efficiency gains of up to 55 percent in high-volume healthcare data environments.
Copyright (c) 2025 Journal of AI-Powered Medical Innovations and Authors https://creativecommons.org/licenses/by/4.0
AI-Driven Cybersecurity and Data Protection Frameworks in Oracle 26AI and Exadata Ecosystems
Enterprise database ecosystems built on Oracle 26AI and Oracle Exadata represent some of the most data-intensive and security-critical environments in modern organizations. The convergence of artificial intelligence capabilities directly into the database engine, as realized in Oracle 26AI, introduces transformative opportunities for cybersecurity automation, anomaly detection, and adaptive data protection. Simultaneously, it introduces new attack surfaces that require rethinking traditional perimeter-based security models. This paper presents a comprehensive examination of AI-driven cybersecurity and data protection frameworks applicable to Oracle 26AI and Exadata deployments, covering threat detection architectures, encryption and key management strategies, identity and access governance, audit and compliance automation, and AI-specific data protection considerations. The paper proposes a layered reference security architecture and evaluates it against regulatory requirements common in healthcare and financial services environments. The analysis demonstrates that frameworks integrating native Oracle security capabilities with AI-driven behavioral analytics and zero-trust network principles substantially reduce mean time to detection and improve compliance posture compared to conventional rule-based approaches.
Hierarchy of Auditory Cortex Adaptation to Signal Degradation. From Acoustics to Prediction
The brain does not process speech as a single stream. Instead, it operates across multiple levels at once — acoustic, voice-selective, prosodic, and multisensory — and each level has its own way of compensating when the signal degrades, whether through noise vocoding, disrupted binaural hearing, or peripheral deafness. This review brings together evidence showing that: (1) the bilateral superior temporal gyrus responds to acoustic degradation largely regardless of whether speech is intelligible; (2) the temporal voice areas (TVA) stay tuned to voices even under severe degradation, drawing on preserved temporal cues; (3) visual prosodic facial movements generate predictive auditory representations before the acoustic signal even arrives; and (4) bilateral cochlear implants normalize cortical activity patterns more effectively than a single implant. Drawing on fMRI, PET, and EEG data, we propose an integrative model of hierarchical cortical adaptation and consider what it means for auditory rehabilitation.
Copyright (c) 2026 Journal of AI-Powered Medical Innovations (International online ISSN 3078-1930)
Generative AI-Driven Drug Discovery Pipelines: Leveraging Cloud-Native Infrastructure for Accelerated Clinical Trials
The integration of generative artificial intelligence into pharmaceutical drug discovery has emerged as one of the most consequential technological shifts in biomedical science over the past decade. This article presents findings from a multi-site observational study conducted across six pharmaceutical research institutions between 2023 and 2025, evaluating the impact of generative AI models and cloud-native computational infrastructure on the efficiency, cost, and success rate of drug discovery pipelines from lead identification through Phase II clinical trials. Across a cohort of 38 drug development programs spanning oncology, neurology, and infectious disease, we demonstrate that programs deploying large-scale generative molecular design models in conjunction with cloud-orchestrated data pipelines reduced median lead-to-candidate timelines by 41.3% (p < 0.001) and reduced computational costs per candidate by 62.7% relative to programs using conventional structure-based methods alone. We further characterize how cloud-native infrastructure, including containerized workloads, scalable genomic data lakes, and federated learning environments — enables previously intractable analyses such as real-time patient stratification and in-silico trial simulation. Our results provide empirical evidence that generative AI is not merely an adjunct to existing discovery methodology but represents a fundamental restructuring of how pharmaceutical candidates are designed, optimized, and validated. These findings carry significant implications for regulatory frameworks, data governance policy, and the economics of drug development globally.
Copyright (c) 2026 Journal of AI-Powered Medical Innovations and Authors https://creativecommons.org/licenses/by/4.0/
Bridging the Translational Gap: How Software Engineering Practices Enable the Deployment of Applied AI in Clinical Settings
The potential of artificial intelligence (AI) in healthcare has been significant, with developments in clinical decision support, disease prediction, diagnostic imaging, and personalized medicine. However, the translation of AI systems from experimental settings to clinical use is still somewhat limited. Much of the literature thus far has focused on model-related successes, such as predictive power and algorithmic correctness, and has paid little attention to the software engineering skills required to make it reliable, safe, scalable, and clinically actionable. As a result, many high-performing models have failed to successfully be adopted in real-world healthcare settings because of issues with interoperability, integration, reproducibility, observability, regulatory compliance and clinician trust. The paper proposes that using applied Artificial Intelligence in the clinical environment is more than just a machine learning problem; it is a software engineering and systems integration problem. The study also employs a structured literature synthesis of research to pinpoint clinical AI implementation tools for building a successful clinical AI, such as data lineage and version control, continuous integration/continuous delivery for machine learning systems, containerization, monitoring and failure-mode analysis, human-in-the-loop monitoring, fairness auditing, and regulatory traceability. On this basis, a framework is proposed for the safe, scalable and trustworthy application of applied AI into clinical workflows, that is, a framework for deployment. The study also highlights the importance of incorporating regulatory and governance considerations into engineering practices to enhance readiness for deployment and institutional trust. To bridge the translational gap in the field of healthcare AI, the focus needs to shift from merely emphasizing the performance of individual algorithms to developing comprehensive, sustainable, and clinically relevant systems that can contribute to the practical implementation of care.
Copyright (c) 2024 Copyright (c) 2024 Journal of AI-Powered Medical Innovations and Authors https://creativecommons.org/licenses/by/4.0/
Multi-Agent AI Systems for Autonomous Hospital Operations: A Framework for Safety, Scalability, and Compliance
Modern hospitals are complex adaptive environments, with dynamic, real-time data streams and complex clinical, administrative and logistical workflows. Yet many healthcare organizations are still hampered by disjointed information systems, ad hoc operations and manual coordination procedures that lead to inefficiencies in patient flow, resource allocation, medication dispensing and staff use. This paper introduces an all-encompassing framework for Multi-Agent Artificial Intelligence Systems (MAIS) aimed at enabling autonomous functioning of hospitals by making decisions in a coordinated, intelligent and decentralized manner. The proposed approach involves the use of specialized interacting agents that are responsible for various critical operational domains, such as patient flow coordination, staff allocation, pharmacy logistics, bed management, and discharge planning, unlike the monolithic AI systems that are used for independent tasks. The structure of the framework is organized around three pillars, safety, scalability and regulatory compliance. The safety aspects are supported by a hierarchical supervisory control, real-time constraint monitoring, fail-safe intervention protocols, and human-in-the-loop escalation mechanisms, which helps to ensure accountability and avoid unsafe autonomous actions. The scalability is realized by making the coordination of agents decentralized, the communication protocols adaptive, and the systems design interoperable for expansion from single unit implementation to enterprise-wide hospital networks. Embedding regulatory compliance is achieved via explainable decision logs, privacy-preserving data governance, automated auditing mechanisms, and compliance with healthcare regulations for AI-powered medical systems and patient data protection. The study uses simulated hospital operational scenarios to highlight the potential of multi-agent intelligence in enhancing the efficiency of hospital operations and optimizing the use of resources, while ensuring the maintenance of human clinical oversight and support. The paper also outlines the implementation challenges, governance aspects and future research directions for the autonomous hospital ecosystem.
SGLT2 Inhibitors vs. Finerenone for Slowing CKD Progression in Hypertensive Diabetic Patients with Obesity: A Comparative Effectiveness Study
Chronic kidney disease continues to be a major cause of illness and death around the world, and it's particularly common in people with type 2 diabetes, high blood pressure, and obesity. When these conditions occur together, it's a very dangerous situation for the kidneys, leading to a quicker loss of kidney function, more heart problems, and generally a worse outlook for the future (Kovesdy 2022; Mallamaci and Tripepi 2024). The usual treatments, including blocking the renin-angiotensin-aldosterone system (RAAS), haven't been very successful at stopping the disease from getting worse, so we need new, more specific drug treatments (Forbes and Gallagher 2020). Recently, SGLT2 inhibitors and finerenone have been shown to protect both the kidneys and the heart. SGLT2 inhibitors work mainly by reducing how much glucose the kidneys reabsorb, correcting the communication between the tubules and glomeruli, and reducing pressure inside the glomeruli, all of which slows down the rate at which estimated glomerular filtration rate (eGFR) declines (Vallon and Verma 2021; Bailey, Day, and Bellary 2022). Finerenone, on the other hand, works by specifically blocking the mineralocorticoid receptor, and in doing so, reduces inflammation and scarring, both important factors in chronic kidney disease getting worse (Agarwal et al. 2022; Filippatos et al. 2022). Both treatments have shown good results in separate tests, but we don't yet have enough information about how they compare to each other in people who have diabetes, high blood pressure, and obesity. This research will assess and contrast how well SGLT2 inhibitors and finerenone work at slowing down the worsening of chronic kidney disease in overweight, diabetic patients with high blood pressure. We're using a 'comparative effectiveness' approach, bringing together information from clinical trials, studies observing patients, and combined data. We'll be looking at how eGFR changes and how quickly the disease reaches advanced stages as the main results, and also at heart problems, hospital admissions, and any side effects from the treatment. New research suggests SGLT2 inhibitors are particularly good at reducing overactivity of the glomeruli and improving blood flow in the kidneys, while finerenone has extra benefits due to its ability to reduce inflammation and scarring. The FIDELITY analysis, for example, showed finerenone significantly lowered both kidney and heart-related problems in people with type 2 diabetes and chronic kidney disease (Agarwal et al. 2022). And SGLT2 inhibitors have regularly and considerably reduced the progression of kidney disease and the risk of heart failure in many different groups of people (Yau et al. 2022; Dabour et al. 2024). We expect this study's results to give an important understanding of how the two therapies work in relation to each other, and how they can complement one another, particularly in people with multiple, serious conditions. By clarifying which is better, this research is designed to help doctors make decisions about treatment and improve how we slow down chronic kidney disease. What's more, it points to the possibility of using the two drugs together; current trials like CONFIDENCE (Green et al. 1023) suggest this might be the next step forward in treating chronic kidney disease. In short, both SGLT2 inhibitors and finerenone are significant improvements in managing chronic kidney disease in patients with obesity, high blood pressure, and diabetes. However, because they work in different ways and have different effects, it's important to have treatments tailored to the individual. We need further trials where the drugs are tested against each other and longer-term studies to decide the best course of treatment and get the best possible results for patients.
Copyright (c) 2024 Journal of AI-Powered Medical Innovations (International online ISSN 3078-1930)
Integrating Generative AI with Autonomous Databases: A Deep Dive into Oracle Database 23ai and Oracle Database 26ai Architecture
The convergence of generative artificial intelligence (GenAI) and autonomous database systems represents one of the most consequential transformations in enterprise data management over the past decade. Oracle Corporation has positioned itself at the forefront of this convergence through two landmark releases: Oracle Database 23ai the first database explicitly branded as AI-integrated and the forthcoming Oracle Database 26ai, which promises a fully AI-native, self-optimizing data platform. This paper presents a comprehensive architectural analysis of both systems, examining how generative AI capabilities are woven into every layer of the database stack, from storage engines and query optimizers to natural-language interfaces and in-database large-language-model (LLM) gateways. We explore Oracle 23ai's flagship features AI Vector Search, Select AI, JSON Relational Duality, and enhanced in-database machine learning and contrast them with the anticipated architectural innovations in Oracle 26ai, including multimodal data support, integrated LLM routing, and autonomous self-healing infrastructure. Through comparative analysis, performance benchmarks, and real-world use cases spanning healthcare, finance, and manufacturing, this paper demonstrates that AI-native autonomous databases are not simply databases augmented with AI, but fundamentally re-architected systems where intelligence is a first-class citizen. Our findings suggest that Oracle's trajectory from 23ai to 26ai maps a clear progression toward databases that generate, understand, and act on knowledge rather than merely storing and retrieving it.
Copyright (c) 2026 Copyright: © The Author(s), 2026. Published by JAPMI. https://creativecommons.org/licenses/by/4.0/
Vaping and Early Periodontal Damage in Teens: Associations with Community Periodontal Index Scores and Salivary Inflammatory Markers
Electronic cigarette (e-cigarette) use has grown dramatically among adolescents, and there has been growing concern about the possible impact on oral and periodontal health. Although the perceived risks of vaping are less than conventional smoking, e-cigarette aerosols contain nicotine, aldehydes, and metal particulates which have the potential to change the oral microenvironment and inflammatory pathways. This study set out to find if e-cigarette use is associated with sub-clinical periodontal changes in high-school students by using Community Periodontal Index (CPI) scores and salivary inflammatory biomarkers as indicators of periodontal changes. A cross-sectional analytical design was used among adolescents aged 14-18 years old adapted into vapers and non-vapers. Clinical oral evaluations were performed by CPI, and the saliva samples were examined for interleukin (IL)-1v, IL-6 and tumor necrosis factor-alpha (TNF-a) levels using enzyme-linked immunosorbent assay (ELISA). Preliminary findings from similar studies have shown higher CPI scores with significantly higher salivary cytokine concentrations in adolescent e-cigarette users than in their non vaping counterparts suggesting the development of early periodontal inflammation before overt clinical disease. These results emphasize vaping as a possible risk factor for early changes in the periodontal tissues of the adolescent and recommend early detection, public health education and preventive measures in school-based oral health programs.
Community Water Fluoridation Rollbacks in Canada: Longitudinal Trends in Dental Caries Incidence Before and After Policy Removal Across Comparable Municipalities
One of the most powerful and fair forms of preventive programs on dental caries among populations has been Community Water Fluoridation (CWF). Nevertheless, the past few years have seen a rise in policy backsliding among Canadian local government because of popular cynicism, perceived health threats and changing governance priorities. The proposed research assesses changes in the dental caries incidence in similar Canadian municipalities before and after CWF stops between 2015 and 2024. Based on the municipal health surveillance data, school-based oral health surveys, and simulated longitudinal epidemiological datasets, the paper will establish significant changes in indices of Decayed, Missing, and Filled Teeth (DMFT) in children after the cessation of fluoridation. The results show that the prevalence of caries increased at the highest rate between two to five years following cessation, especially in the low-income group and the peri-urban groups. The discussion indicates the need to apply evidence-based continuity of policy and emphasizes the socio-behavioral and ethical ambiguities of CWF decisions.
Dental anxiety as a hidden access barrier: prevalence, sociodemographic predictors, and service-utilization effects
Another major, yet significantly under-acknowledged cause of lower utilization of oral healthcare services is dental anxiety. Although there has been increased dental technology coupled with the focus on the patient, fear and anxiety are playing a role in ensuring that individuals do not get timely treatment resulting in the worsening of the oral health condition. This paper will cover the commonality of dental phobia, its sociodemographic predictors, as well as the effects of dental phobia on patterns of service uptake, especially in vulnerable groups. This study relies on a multidisciplinary literature review, thus showing how the age, gender, socioeconomic status, previous trauma, and mental health stigma augment the effects of dental fear. The article claims an oral health structural barrier is the hidden element of dental anxiety that transpires into greater oral health disparity by synthesizing international and regional data, especially with low- and middle-income situations. The results promote a universal culturally competent, and trauma-sensitive system of dental medicine, based on the trust in advance of screening and anxiety-reduction methods. Finally, the problem of dental anxiety is important not only to enhance oral health outcomes but to create equity in access to basic health services.
Patient Outcome Prediction with Artificial Intelligence: Innovation and Ethical Challenges
Predictive analytics is increasingly recognized as a transformative tool in healthcare, offering the potential to enhance clinical decision-making, reduce hospital readmission rates, and improve overall patient outcomes. At the core of these advancements is machine learning (ML), which enables the development of predictive models capable of analyzing vast amounts of patient data to uncover patterns and forecast health trajectories. This paper explores the application of ML techniques in healthcare predictive analytics, providing an overview of commonly employed algorithms, evaluating their effectiveness, and outlining key challenges and directions for future research. To illustrate the practical application, we present a case study that employs supervised learning models to predict patient readmission rates using real-world healthcare datasets. The comparative analysis of model accuracy highlights the strengths and limitations of different approaches in real-world clinical contexts. Findings suggest that ML-driven predictive analytics can significantly improve healthcare efficiency, reduce operational costs, and enhance patient care through early intervention and proactive risk management strategies.
The Political Economy of Universal Health Coverage (UHC): Barriers to Implementation in Fragile States
Universal Health Coverage (UHC) has become a global health priority since its first emergence in 2007, and it seeks to guarantee that every person is able to get health services when they need it without experiencing any form of financial jeopardy. The realization of UHC in a fragile state is, however, unique because of weak general governance, political frailty, economical weaknesses and less organized health systems. This paper looks at the political economy of implementing UHC in fragile states, and explores how challenges of institutional weakness, donor dependency, and socio-politics make efforts cumbersome. With a thorough literature and policy review across 3 regions (Sub-Saharan Africa, Southeast Asia, and the Middle East), the research paper identifies structural obstacles, such as low fiscal capacity, lack of development of health workforce, and mismatch between national priorities and external aid. The evidence shows that to implement successful UHC strategies, it is not just technical health system strengthening that is needed, but also inclusive governance reform, sustainable finance mechanisms, and robust political commitment. The article highlights how the involvement of community and the development of trust can aid in strengthening the uptake of policy and powering service delivery. Policy suggestions prioritize the coordination of donor efforts with national plans and the importance of fiscal sustainability, investment of health infrastructure and human resources, and the opportunity to use UHC as a means of stabilizing a wider socio-political situation. Combining insights into political economy with health systems analysis, this paper offers a new body of knowledge on how to overcome the obstacles to UHC in fragile settings, as well as contributing to the international debate on equitable access to health.
AI-Enhanced Data Integration Frameworks for Multimodal Clinical Research
The growing complexity of clinical research demands effective integration of diverse data modalities, including electronic health records, medical imaging, genomic sequences, and wearable sensor data. Traditional data management approaches often struggle to ensure interoperability, scalability, and real-time processing. This study proposes an AI-enhanced data integration framework tailored for multimodal clinical research. By leveraging machine learning, natural language processing, and advanced data harmonization techniques, the framework enables seamless fusion of structured and unstructured data across heterogeneous sources. The proposed architecture enhances data quality, improves analytical efficiency, and supports reproducibility in clinical studies. Case applications demonstrate its potential to accelerate disease modeling, personalized treatment strategies, and predictive analytics, while maintaining compliance with healthcare data governance standards. Findings suggest that AI-driven integration not only optimizes multimodal research workflows but also paves the way for more holistic and evidence-based clinical decision-making.
Deep Learning Approaches for Automated Organ Segmentation in Large-Scale CT Cohorts
Automated organ segmentation in computed tomography (CT) imaging plays a pivotal role in clinical diagnosis, treatment planning, and large-scale population studies. Traditional segmentation techniques are often limited by variability in organ shape, size, and contrast, making them less effective in handling large and diverse datasets. Recent advancements in deep learning have introduced robust approaches that significantly improve segmentation accuracy and efficiency. This article reviews state-of-the-art deep learning models, including convolutional neural networks (CNNs), U-Net architectures, and transformer-based frameworks, for organ segmentation in large-scale CT cohorts. We discuss training strategies, data augmentation, and transfer learning methods that enhance model generalization across heterogeneous datasets. Furthermore, the study explores challenges such as class imbalance, annotation scarcity, and computational costs, alongside potential solutions like weakly supervised learning and federated learning. The findings demonstrate that deep learning not only accelerates automated organ segmentation but also contributes to scalable and reproducible pipelines for clinical and research applications.
Statistical Remarks on Rural Healthcare: A Detailed Study of AI Medical Systems in Bangladesh
This research examines the integration of mathematical intelligence systems into rural healthcare delivery in Bangladesh, highlighting both the achievements and structural challenges of implementation. As a developing nation with substantial disparities in healthcare access, Bangladesh has systematically pursued computational models to address the needs of underserved rural populations. The study traces the evolution of digital health infrastructure from basic electronic records (2012–2016) to predictive, algorithmically enhanced diagnostic and surveillance systems (2021–2023). Case studies illustrate significant empirical outcomes, including accurate disease forecasting, improved detection of tuberculosis and diabetes, enhanced maternal health risk classification, and pediatric malnutrition analysis. Mobile health applications and web-based dashboards have expanded healthcare accessibility, enabling early diagnosis, efficient data collection, and epidemiological surveillance in resource-constrained environments. Despite notable successes, persistent obstacles include data infrastructure deficiencies, limited clinical feature representation, and inadequate rural healthcare facilities. Furthermore, Bangladesh’s legislative vacuum in health data privacy and its outdated regulatory framework for medical devices raise ethical and governance challenges that complicate algorithmic adoption. The study argues that sustainable integration of AI systems requires three interdependent priorities: (1) strengthening public-private partnerships for scalable deployment, (2) implementing community health worker training in algorithmic tools, and (3) constructing context-specific datasets to improve predictive accuracy. Bangladesh’s case demonstrates both the transformative potential and the limitations of AI in rural healthcare. The findings suggest that future success depends not solely on computational advances but on building robust institutional frameworks that align technology with equity, ethics, and sustainability.
Detecting and Mitigating Hallucinations in Large Language Models (LLMs) Using Reinforcement Learning in Healthcare
Large Language Models (LLMs) have demonstrated significant potential in enhancing healthcare services, including clinical decision support, patient engagement, and medical research. However, their susceptibility to hallucinations generating factually incorrect, misleading, or fabricated information poses serious risks in high-stakes medical contexts. This study proposes a reinforcement learning (RL)-based framework to detect and mitigate hallucinations in LLM outputs tailored for healthcare applications. The approach integrates domain-specific knowledge bases with reward-driven fine-tuning to penalize inaccurate or unsupported responses and reinforce factual precision. The model leverages automated fact-checking, uncertainty estimation, and expert-in-the-loop feedback to refine its reasoning process. Experimental evaluation across multiple healthcare datasets, including medical question-answering and clinical note summarization, shows a substantial reduction in hallucination frequency while preserving response fluency and contextual relevance. This research offers a scalable, adaptive strategy for improving the trustworthiness, safety, and ethical deployment of LLMs in healthcare systems.
Blockchain for Secure Data Lifecycle Management in FDA-Regulated Environments
The integration of blockchain technology into FDA-regulated environments presents a transformative solution for addressing critical challenges in secure data lifecycle management. This article explores how blockchain’s inherent properties—immutability, decentralized consensus, and cryptographic auditability—enhance data integrity, traceability, and compliance within pharmaceutical manufacturing and supply chains. Through case studies involving industry leaders like Johnson & Johnson and Pfizer, we demonstrate the efficacy of hybrid blockchain architectures in balancing regulatory requirements (e.g., 21 CFR Part 11, ALCOA+ principles) with operational efficiency, achieving a 40% reduction in audit trail generation time and 100% compliance in mock FDA inspections. The study highlights the role of collaborative frameworks, such as regulatory sandboxes and the FDA’s Emerging Technology Program, in accelerating the validation of blockchain systems while mitigating implementation costs. Furthermore, we propose actionable strategies for global harmonization, including alignment with ISO 8000-2 data quality standards and NIST cybersecurity protocols. Looking ahead, the convergence of blockchain with AI/ML-driven predictive analytics emerges as a pivotal innovation, enabling real-time anomaly detection and autonomous compliance adaptation. This research underscores blockchain’s potential to redefine Pharma 4.0, offering a roadmap for stakeholders to navigate technical, regulatory, and economic barriers while advancing secure, scalable data management ecosystems.
Copyright (c) 2024 Copyright: © The Author(s), 2024. Published by JAPMI. https://creativecommons.org/licenses/by/4.0/
Impact of GAMP 5 Guidelines on Validation of AI-Powered Medical Device Software
The integration of artificial intelligence (AI) into medical device software has revolutionized healthcare by enhancing diagnostic accuracy, treatment efficiency, and patient outcomes. However, ensuring the reliability, safety, and regulatory compliance of AI-powered medical devices presents significant challenges. The Good Automated Manufacturing Practice (GAMP 5) guidelines provide a structured framework for validating automated systems, including AI-driven medical software. This study explores the impact of GAMP 5 guidelines on the validation process of AI-powered medical devices, addressing key aspects such as risk management, data integrity, and lifecycle management. Through a detailed analysis of regulatory requirements and case studies, this research highlights best practices for aligning AI-driven medical device validation with GAMP 5 principles. The findings underscore the importance of robust validation methodologies to ensure compliance, improve software performance, and enhance patient safety.
Evaluating challenges and solutions for ensuring regulatory compliance in cloud-hosted LIMS platforms used in pharmaceutical and biotech industries.
The adoption of cloud-hosted Laboratory Information Management Systems (LIMS) in the pharmaceutical and biotech industries offers transformative benefits, including scalability, cost efficiency, and remote collaboration. However, ensuring regulatory compliance in these environments—particularly with standards such as 21 CFR Part 11, GDPR, and GxP—presents significant challenges. This study evaluates the key obstacles faced by organizations leveraging cloud-based LIMS, including data integrity risks, audit trail reliability, electronic signature non-repudiation, and vendor accountability in shared infrastructure models. Through a mixed-methods approach combining literature analysis, case studies, and interviews with industry experts, the research identifies actionable solutions to these challenges. Findings highlight the critical role of robust encryption, immutable audit logs, risk-based validation frameworks, and real-time compliance monitoring tools. The study also underscores the importance of vendor partnerships, staff training, and agile governance models to align cloud agility with regulatory rigor. Results demonstrate that while multi-tenancy risks and jurisdictional ambiguities persist, a hybrid approach combining technical safeguards and organizational protocols can achieve compliance without compromising innovation. This work provides a roadmap for pharmaceutical and biotech firms to navigate the evolving regulatory landscape while harnessing the full potential of cloud-hosted LIMS.
Ensuring Data Integrity in Pharmaceutical Quality Systems: A Risk-Based Approach
The integrity of data within pharmaceutical quality systems is crucial to ensuring product quality, patient safety, and regulatory compliance. This paper presents a risk-based approach to safeguarding data integrity across pharmaceutical quality systems. It discusses the regulatory frameworks, industry best practices, and the potential risks associated with data manipulation, loss, or corruption. By applying risk assessment tools, the paper outlines strategies for identifying vulnerable points in data management processes and proposes corrective actions to mitigate these risks. Furthermore, it emphasizes the importance of a robust culture of data integrity and continuous monitoring to maintain system reliability. The approach helps pharmaceutical companies comply with Good Manufacturing Practices (GMP) and other regulatory standards while ensuring the accuracy and trustworthiness of critical data.
Automating FDA Compliance: The Role of AI in Computer System Validation (CSV)
The increasing adoption of artificial intelligence (AI) in the pharmaceutical and healthcare industries has transformed regulatory compliance processes, particularly in Computer System Validation (CSV). The U.S. Food and Drug Administration (FDA) mandates strict compliance with CSV to ensure the reliability, accuracy, and integrity of computer systems used in drug development, manufacturing, and clinical trials. Traditional CSV methods are often time-consuming, labor-intensive, and prone to human error. AI-driven automation offers a solution by streamlining validation processes, reducing costs, and enhancing regulatory adherence. This paper explores the role of AI in automating CSV, highlighting its potential to improve efficiency, ensure data integrity, and minimize compliance risks. Additionally, it discusses the challenges and regulatory considerations associated with AI-driven CSV, providing insights into how organizations can leverage AI to meet FDA requirements effectively.
The Role of AI in Tackling Epidemics: Lessons from Recent Outbreaks
Artificial Intelligence (AI) has emerged as a transformative tool in managing epidemics, offering innovative solutions to detect, predict, and mitigate the spread of infectious diseases. This paper explores the role of AI in tackling recent outbreaks, such as COVID-19, Ebola, and Zika, emphasizing its contributions to real-time data analysis, contact tracing, and outbreak prediction. Key AI applications, including machine learning models for disease forecasting, natural language processing for analyzing public health data, and AI-powered diagnostic tools, are examined. Additionally, the study discusses the challenges of implementing AI in epidemic management, such as data privacy concerns, technological infrastructure disparities, and the need for global collaboration. Lessons from these outbreaks underline the importance of integrating AI into global health systems to enhance preparedness, response, and resilience against future public health crises.
Ethical Challenges and Opportunities in AI-Driven Healthcare
The integration of Artificial Intelligence (AI) into healthcare has brought transformative benefits, including enhanced diagnostics, personalized medicine, and improved operational efficiency. However, this rapid adoption also presents ethical challenges that must be addressed to ensure equitable and responsible implementation. Key issues include data privacy and security, algorithmic bias, transparency, accountability, and the potential for AI to exacerbate existing health disparities. This article examines these ethical dilemmas, offering a comprehensive analysis of their implications for patients, healthcare providers, and policymakers. In parallel, it explores the opportunities AI presents to uphold ethical standards, such as improving global health equity, advancing patient-centered care, and fostering trust through explainable AI models. By addressing these challenges and leveraging opportunities, stakeholders can pave the way for an ethically sound future in AI-driven healthcare.
Copyright (c) 2025 Copyright: © The Author(s), 2024. Published by JAPMI. https://creativecommons.org/licenses/by/4.0/
AI and Healthcare in 2030: Predictions and Pathways
The intersection of artificial intelligence (AI) and healthcare is poised to transform medical practices by 2030, reshaping diagnostics, treatment protocols, and patient care. This paper explores the key advancements expected in AI-driven healthcare, including precision medicine, predictive analytics, and automated workflows, and the challenges posed by ethical considerations, data security, and regulatory frameworks. Emphasis is placed on the role of AI in enhancing access to care, reducing costs, and empowering patients through personalized solutions. Furthermore, the discussion highlights pathways for integrating AI technologies responsibly to ensure equity and trust in healthcare systems. By envisioning AI's potential and addressing its risks, this work aims to provide a roadmap for stakeholders to navigate the evolving healthcare landscape effectively.
Optimizing Mathematical Problem-Solving Reasoning Chains and Personalized Explanations Using Large Language Models: A Study in Applied Mathematics Education
This study investigates the optimization of mathematical problem-solving through Large Language Models (LLMs), focusing on developing enhanced reasoning chains and personalized explanations in applied mathematics education. The research implements a novel framework integrating LLM-based reasoning chain generation with adaptive personalization algorithms, demonstrating significant improvements in student learning outcomes. Through a comprehensive experimental evaluation involving 2,854 students across different proficiency levels, the system achieved a 98.7% accuracy rate in mathematical problem-solving and a 92.3% user satisfaction rate. Implementing personalized explanation systems resulted in a 27.8% improvement in student comprehension and a 31.5% increase in engagement rates. Performance analysis revealed robust scalability, maintaining response times below 312ms under peak loads of 850 requests per second. The findings demonstrate the effectiveness of LLM-based approaches in enhancing mathematics education through automated reasoning chain generation and personalized instruction. The research contributes to advancing AI-assisted educational technologies and provides valuable insights for developing intelligent tutoring systems in STEM education.
Hyper-personalization Through Long-Term Sentiment Tracking in User Behavior: A Literature Review
Hyper-personalization, the process of tailoring suitable or personable content, products and experiences to individual users, has become increasingly intelligent and sophisticated through advancements in artificial intelligence (AI) and natural language processing (NLP). This literature review focuses on the niche area of long-term sentiment tracking to enhance hyper-personalization. By examining modern methodologies, applications, and ethical implications, the review underscores how sentiment analysis over time facilitates deeper understanding of user behavior, facilitating more effective engagement. The review also acknowledges challenges such as data privacy, sentiment drift, and algorithmic bias, providing a roadmap for future research directions.